These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 57520)

  • 21. Safety and efficacy of "Alice" influenza virus vaccine in normal healthy adults.
    Zaky DA; Douglas RG; Betts RF; Roth FK; Rinehart CJ; Hogan PW
    J Infect Dis; 1976 Jun; 133(6):669-75. PubMed ID: 946973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity,, immunogenicity, and protection efficacy.
    Rytel MW; Jackson LJ; Ferstenfeld JE; Rosenkranz MA
    J Infect Dis; 1975 Dec; 132(6):652-9. PubMed ID: 1202110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza at Christ's Hospital: March, 1974.
    Hoskins TW; Davies JR; Smith AJ; Allchin A; Miller CL; Pollock TM
    Lancet; 1976 Jan; 1(7951):105-8. PubMed ID: 54631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dose on antibody response to subunit influenza vaccine.
    Feery BJ; Hampson AW; Forsyth JR; Evered MG
    Med J Aust; 1977 Sep; 2(10):324-7. PubMed ID: 927252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines.
    Shvartsman YS; Agranovskaya EN; Zykov MP
    J Infect Dis; 1977 May; 135(5):697-705. PubMed ID: 858947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective efficacy of a live, attenuated, influenza virus vaccine ('Alice' strain).
    Prinzie A; Delem A; Huygelen C
    Postgrad Med J; 1976 Jun; 52(608):395-8. PubMed ID: 785431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increase in the effectiveness of anti-influenza immunization by use of a combination of inactivated and live vaccine].
    Smorodintsev AA; Orlov VA; Ermolaeva OM; Zhilova GP
    Vopr Virusol; 1978; (5):602-7. PubMed ID: 735019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of elicited antibody responses, clinical reactions and transmissibility of WRL 105 live influenza vaccine.
    Moffat MA; Stealey VM; Freestone DS; Macdonald A
    J Biol Stand; 1976 Apr; 4(2):91-5. PubMed ID: 777003
    [No Abstract]   [Full Text] [Related]  

  • 32. Homologous and heterologous antibody responses to subunit influenza virus vaccine.
    Feery BJ; Evered MG; Hayes K
    J Hyg (Lond); 1978 Dec; 81(3):331-6. PubMed ID: 581591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic reactions to influenza B vaccine.
    Gwaltney JM; DeSanctis AN; Metzgar DP; Hendley JO
    Am J Epidemiol; 1977 Mar; 105(3):252-60. PubMed ID: 322477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection.
    Beutner KR; Chow T; Rubi E; Strussenberg J; Clement J; Ogra PL
    J Infect Dis; 1979 Dec; 140(6):844-50. PubMed ID: 396336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response to combined live influenza virus vaccines administered intranasally.
    Peetermans J; Lamy F; Delem A
    Dev Biol Stand; 1975; 28():340-6. PubMed ID: 1126578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R
    J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Homologous and heterologous antibody response induced in man by anti-influenza vaccine containing A/England/42/72 and b/Massachusetts/71].
    Galanti B; Picciotto L; Ruggiero G; Romano E; Vaccaro L
    Boll Ist Sieroter Milan; 1976 Mar; 55(71):13-7. PubMed ID: 1021152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
    Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
    Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
    Iorio AM; Camilloni B; Basileo M; Neri M; Lepri E; Spighi M
    Gerontology; 2007; 53(6):411-8. PubMed ID: 17975317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.